| Symbol | Company | Weighting |
|---|---|---|
| NTRA | NATERA INC | 5.49% |
| ABBV | ABBVIE INC | 5.38% |
| VRTX | VERTEX PHARMACEUTICALS INC | 5.33% |
| UNH | UNITEDHEALTH GROUP INC | 5.03% |
| AMGN | AMGEN CORP | 4.82% |
| CI | THE CIGNA GROUP | 4.51% |
| GILD | GILEAD SCIENCES INC | 4.31% |
| ZTS | ZOETIS INC | 4.06% |
| TMO | THERMO FISHER SCIENTIFIC INC | 3.98% |
| REGN | REGENERON PHARMACEUTICALS | 3.82% |
| ELV | ELEVANCE HEALTH INC | 3.60% |
| DHR | DANAHER CORP | 3.50% |
| JNJ | JOHNSON & JOHNSON | 3.47% |
| CNC | CENTENE CORP | 3.45% |
| BMY | BRISTOL MYERS SQUIBB CO | 3.45% |
| MRK | MERCK & CO. NEW | 3.42% |
| CVS | CVS HEALTH CORPORATION | 3.18% |
| HUM | HUMANA INC | 2.65% |
| UTHR | UNITED THERAPEUTICS CORPS | 2.64% |
| PFE | PFIZER INC | 2.56% |
| EHC | ENCOMPASS HEALTH CORP NPV | 2.49% |
| CHE | CHEMED CORP | 2.17% |
| MOH | MOLINA HEALTHCARE INC | 2.07% |
| HALO | HALOZYME THERAPEUTICS INC | 2.01% |
| A | AGILENT TECHNOLOGIES | 1.85% |
| AVTR | AVANTOR, INC. | 1.64% |
| IDXX | IDEXX LABS CORP | 1.60% |
| JAZZ | JAZZ PHARMACEUTICALS PLC | 1.56% |
| IQV | IQVIA HOLDINGS INC | 1.40% |
| PRVA | PRIVIA HEALTH GROUP INC | 0.97% |
| CERT | CERTARA INC | 0.96% |
| BIIB | BIOGEN INC | 0.92% |
| QDEL | QUIDELORTHO CORP NPV | 0.79% |
| VLTO | VERALTO CORP | 0.53% |
| AMLX | AMYLYX PHARMACEUTICALS INC | 0.40% |
Read a prospectus and summary prospectus (if available) carefully before investing. It contains the investment objective, risks charges, expenses and the other information, which should be considered carefully before investing. To obtain a prospectus and summary prospectus (if available) click here or call 800.820.0888.
Investing involves risk, including the possible loss of principal.
Guggenheim Investments represents the following affiliated investment management businesses of Guggenheim Partners, LLC: Guggenheim Partners Investment Management, LLC, Security Investors, LLC, Guggenheim Wealth Solutions, LLC, Guggenheim Funds Distributors, LLC, Guggenheim Funds Investment Advisors, LLC, Guggenheim Corporate Funding, LLC, Guggenheim Partners Europe Limited, Guggenheim Partners Japan Limited, and GS GAMMA Advisors, LLC. Securities offered through Guggenheim Funds Distributors, LLC.
© 2024 Guggenheim Investments. All Rights Reserved.
Research our firm with FINRA Broker Check.
• Not FDIC Insured • No Bank Guarantee • May Lose Value
This website is directed to and intended for use by citizens or residents of the United States of America only. The material provided on this website is not intended as a recommendation or as investment advice of any kind, including in connection with rollovers, transfers, and distributions. Such material is not provided in a fiduciary capacity, may not be relied upon for or in connection with the making of investment decisions, and does not constitute a solicitation of an offer to buy or sell securities. All content has been provided for informational or educational purposes only and is not intended to be and should not be construed as legal or tax advice and/or a legal opinion. Always consult a financial, tax and/or legal professional regarding your specific situation. Investing involves risk, including the possible loss of principal.